1. Home
  2. TCBP vs ATXG Comparison

TCBP vs ATXG Comparison

Compare TCBP & ATXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCBP
  • ATXG
  • Stock Information
  • Founded
  • TCBP 2013
  • ATXG 2014
  • Country
  • TCBP United Kingdom
  • ATXG China
  • Employees
  • TCBP N/A
  • ATXG N/A
  • Industry
  • TCBP Biotechnology: Biological Products (No Diagnostic Substances)
  • ATXG Professional Services
  • Sector
  • TCBP Health Care
  • ATXG Consumer Discretionary
  • Exchange
  • TCBP Nasdaq
  • ATXG Nasdaq
  • Market Cap
  • TCBP 831.0K
  • ATXG 5.4M
  • IPO Year
  • TCBP 2022
  • ATXG N/A
  • Fundamental
  • Price
  • TCBP $1.69
  • ATXG $0.85
  • Analyst Decision
  • TCBP Strong Buy
  • ATXG
  • Analyst Count
  • TCBP 1
  • ATXG 0
  • Target Price
  • TCBP $48.00
  • ATXG N/A
  • AVG Volume (30 Days)
  • TCBP 632.6K
  • ATXG 18.7K
  • Earning Date
  • TCBP 11-25-2024
  • ATXG 02-14-2025
  • Dividend Yield
  • TCBP N/A
  • ATXG N/A
  • EPS Growth
  • TCBP N/A
  • ATXG N/A
  • EPS
  • TCBP N/A
  • ATXG N/A
  • Revenue
  • TCBP N/A
  • ATXG $4,549,310.00
  • Revenue This Year
  • TCBP N/A
  • ATXG N/A
  • Revenue Next Year
  • TCBP N/A
  • ATXG N/A
  • P/E Ratio
  • TCBP N/A
  • ATXG N/A
  • Revenue Growth
  • TCBP N/A
  • ATXG N/A
  • 52 Week Low
  • TCBP $1.43
  • ATXG $0.49
  • 52 Week High
  • TCBP $523.20
  • ATXG $1.44
  • Technical
  • Relative Strength Index (RSI)
  • TCBP 28.01
  • ATXG 45.44
  • Support Level
  • TCBP $1.43
  • ATXG $0.83
  • Resistance Level
  • TCBP $2.19
  • ATXG $0.92
  • Average True Range (ATR)
  • TCBP 0.28
  • ATXG 0.08
  • MACD
  • TCBP 0.19
  • ATXG -0.02
  • Stochastic Oscillator
  • TCBP 20.57
  • ATXG 11.17

About TCBP TC BioPharm (Holdings) plc

TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.

About ATXG Addentax Group Corp.

Addentax Group Corp is an investment holding company. The company through its operating subsidiaries functions in the following segments; Garment manufacturing; Logistics services; Property management and subleasing. It generates maximum revenue from the Logistics services segment which provides logistics services including storage, transportation, warehousing, handling, packaging, and order processing. It also provides customs declaration and tax clearance services to its customers who export goods overseas. Geographically, the company derives all of its revenue from China.

Share on Social Networks: